Works matching AU Toi, Yukihiro

Results: 18

Cardiovascular adverse events in patients with lung cancer treated with immune checkpoint inhibitors: a nationwide database study.

Published in:

Oncologist, 2025, v. 30, n. 6, p. 1, doi. 10.1093/oncolo/oyaf151

By:

Isawa, Tsuyoshi;
Togashi, Shintaro;
Taguri, Masataka;
Toi, Yukihiro;
Sugawara, Shunichi;
Toyoda, Shigeru

Publication type:

Article

Incidence, Clinical Characteristics, and Predictors of Cardiovascular Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.

Published in:

Oncologist, 2022, v. 27, n. 5, p. e410, doi. 10.1093/oncolo/oyac056

By:

Isawa, Tsuyoshi;
Toi, Yukihiro;
Sugawara, Shunichi;
Taguri, Masataka;
Toyoda, Shigeru

Publication type:

Article

Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer.

Published in:

Oncologist, 2020, v. 25, n. 3, p. e536, doi. 10.1634/theoncologist.2019-0550

By:

Aso, Mari;
Toi, Yukihiro;
Sugisaka, Jun;
Aiba, Tomoiki;
Kawana, Sachiko;
Saito, Ryohei;
Ogasawara, Takahiro;
Tsurumi, Kyoji;
Ono, Kana;
Shimizu, Hisashi;
Domeki, Yutaka;
Terayama, Keisuke;
Kawashima, Yosuke;
Nakamura, Atsushi;
Yamanda, Shinsuke;
Kimura, Yuichiro;
Honda, Yoshihiro;
Sugawara, Shunichi

Publication type:

Article

Association of Immune‐Related Adverse Events with Clinical Benefit in Patients with Advanced Non‐Small‐Cell Lung Cancer Treated with Nivolumab.

Published in:

Oncologist, 2018, v. 23, n. 11, p. 1358, doi. 10.1634/theoncologist.2017-0384

By:

Toi, Yukihiro;
Sugawara, Shunichi;
Kawashima, Yosuke;
Aiba, Tomoiki;
Kawana, Sachiko;
Saito, Ryohei;
Tsurumi, Kyoji;
Suzuki, Kana;
Shimizu, Hisashi;
Sugisaka, Jun;
Ono, Hirotaka;
Domeki, Yutaka;
Terayama, Keisuke;
Nakamura, Atsushi;
Yamanda, Shinsuke;
Kimura, Yuichiro;
Honda, Yoshihiro

Publication type:

Article

Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase.

Published in:

Advances in Therapy, 2023, v. 40, n. 11, p. 4928, doi. 10.1007/s12325-023-02648-1

By:

Inui, Naoki;
Toi, Yukihiro;
Yoneshima, Yasuto;
Morise, Masahiro;
Hata, Akito;
Kubota, Kaoru;
Saeki, Toshiaki;
Tamura, Tomohide

Publication type:

Article

Association of immune‐related pneumonitis with clinical benefit of anti‐programmed cell death‐1 monotherapy in advanced non‐small cell lung cancer.

Published in:

Cancer Medicine, 2021, v. 10, n. 14, p. 4796, doi. 10.1002/cam4.4045

By:

Ono, Kana;
Ono, Hirotaka;
Toi, Yukihiro;
Sugisaka, Jun;
Aso, Mari;
Saito, Ryohei;
Kawana, Sachiko;
Aiba, Tomoiki;
Odaka, Tetsuo;
Matsuda, Suguru;
Saito, Shin;
Narumi, Akane;
Ogasawara, Takahiro;
Shimizu, Hisashi;
Domeki, Yutaka;
Terayama, Keisuke;
Kawashima, Yosuke;
Nakamura, Atsushi;
Yamanda, Shinsuke;
Kimura, Yuichiro

Publication type:

Article

Prospective Multicenter Study of Chemotherapy-Induced Clostridium (Clostridioides) difficile Infection in Patients With Lung Cancer: North Japan Lung Cancer Study Group Trial 1204.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.685320

By:

Toi, Yukihiro;
Kobayashi, Takao;
Harada, Toshiyuki;
Nakagawa, Taku;
Mori, Yoshiaki;
Kuda, Tomoya;
Sugawara, Shunichi

Publication type:

Article

Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non-small cell lung cancer patients with impaired renal function: RESTART trial.

Published in:

2022

By:

Shiraishi, Yoshimasa;
Kishimoto, Junji;
Shimose, Takayuki;
Toi, Yukihiro;
Sugawara, Shunichi;
Okamoto, Isamu

Publication type:

journal article

Observational study of chemotherapy-induced Clostridium difficile infection in patients with lung cancer.

Published in:

International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1046, doi. 10.1007/s10147-018-1304-5

By:

Toi, Yukihiro;
Sugawara, Shunichi;
Kobayashi, Takao;
Terayama, Keisuke;
Honda, Yoshihiro

Publication type:

Article

Association between immune-related adverse event timing and treatment outcomes.

Published in:

OncoImmunology, 2022, v. 11, n. 1, p. 1, doi. 10.1080/2162402X.2021.2017162

By:

Hsiehchen, David;
Naqash, Abdul Rafeh;
Espinoza, Magdalena;
Von Itzstein, Mitchell S.;
Cortellini, Alessio;
Ricciuti, Biagio;
Owen, Dwight H.;
Laharwal, Mehak;
Yukihiro Toi;
Burke, Michael;
Yang Xie;
Gerber, David E.

Publication type:

Article

Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.

Published in:

2020

By:

Naqash, Abdul Rafeh;
Ricciuti, Biagio;
Owen, Dwight H.;
Florou, Vaia;
Toi, Yukihiro;
Cherry, Cynthia;
Hafiz, Maida;
De Giglio, Andrea;
Muzaffar, Mavish;
Patel, Sandip H.;
Sugawara, Shunichi;
Burkart, Jarred;
Park, Wungki;
Chiari, Rita;
Sugisaka, Jun;
Otterson, Gregory A.;
de Lima Lopes, Gilberto;
Walker, Paul R.

Publication type:

Correction Notice

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1177, doi. 10.1007/s00262-020-02536-5

By:

Naqash, Abdul Rafeh;
Ricciuti, Biagio;
Owen, Dwight H.;
Florou, Vaia;
Toi, Yukihiro;
Cherry, Cynthia;
Hafiz, Maida;
De Giglio, Andrea;
Muzaffar, Mavish;
Patel, Sandip H.;
Sugawara, Shunichi;
Burkart, Jarred;
Park, Wungki;
Chiari, Rita;
Sugisaka, Jun;
Otterson, Gregory A.;
de Lima Lopes, Gilberto;
Walker, Paul R.

Publication type:

Article

First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.

Published in:

Japanese Journal of Clinical Oncology, 2024, v. 54, n. 4, p. 452, doi. 10.1093/jjco/hyad195

By:

Imai, Hisao;
Kijima, Takashi;
Azuma, Koichi;
Kishi, Kazuma;
Saito, Haruhiro;
Yamaguchi, Teppei;
Tanizaki, Junko;
Yoneshima, Yasuto;
Fujita, Kohei;
Watanabe, Satoshi;
Kitazono, Satoru;
Fukuhara, Tatsuro;
Hataji, Osamu;
Toi, Yukihiro;
Mizutani, Hideaki;
Hamakawa, Yusuke;
Maemondo, Makoto;
Ohsugi, Tomoyuki;
Suzuki, Keisuke;
Horinouchi, Hidehito

Publication type:

Article

Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge.

Published in:

Thoracic Cancer, 2023, v. 14, n. 31, p. 3140, doi. 10.1111/1759-7714.15107

By:

Sugisaka, Jun;
Toi, Yukihiro;
Kawashima, Yosuke;
Domeki, Yutaka;
Aiba, Tomoiki;
Kawana, Sachiko;
Nakamura, Atsushi;
Yamanda, Shinsuke;
Kimura, Yuichiro;
Sugawara, Shunichi

Publication type:

Article

Anti-nuclear antibody and a granuloma could be biomarkers for iCIs-related hepatitis by anti-PD-1 treatment.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07770-8

By:

Kondo, Yasuteru;
Akahira, Junichi;
Morosawa, Tatsuki;
Toi, Yukihiro;
Endo, Akashi;
Satio, Hiroaki;
Endo, Mareyuki;
Sugawara, Shunichi;
Tanaka, Yasuhito

Publication type:

Article

Gene expression signatures as candidate biomarkers of response to PD-1 blockade in non-small cell lung cancers.

Published in:

PLoS ONE, 2021, v. 16, n. 11, p. 1, doi. 10.1371/journal.pone.0260500

By:

Aiba, Tomoiki;
Hattori, Chieko;
Sugisaka, Jun;
Shimizu, Hisashi;
Ono, Hirotaka;
Domeki, Yutaka;
Saito, Ryohei;
Kawana, Sachiko;
Kawashima, Yosuke;
Terayama, Keisuke;
Toi, Yukihiro;
Nakamura, Atsushi;
Yamanda, Shinsuke;
Kimura, Yuichiro;
Suzuki, Yutaka;
Niida, Atsushi;
Sugawara, Shunichi

Publication type:

Article

Successful Application of Tocilizumab in a Patient With Neoadjuvant Immunochemotherapy‐Induced Cytokine Release Syndrome.

Published in:

Cancer Reports, 2024, v. 7, n. 7, p. 1, doi. 10.1002/cnr2.2145

By:

Minami, Soichiro;
Kawashima, Yosuke;
Munakata, Yasuhiko;
Matsuno, Masahiro;
Hara, Shuichiro;
Yamazaki, Yusuke;
Doman, Tsuyoshi;
Saito, Shin;
Odaka, Tetsuo;
Ogasawara, Takahiro;
Shimizu, Hisashi;
Sugisaka, Jun;
Aiba, Tomoiki;
Toi, Yukihiro;
Yamanda, Shinsuke;
Kimura, Yuichiro;
Sugawara, Shunichi

Publication type:

Article

Successful application of lorlatinib in a 23‐year‐old patient with anaplastic lymphoma kinase (ALK)‐positive lung cancer and multiple brain metastases.

Published in:

Cancer Reports, 2024, v. 7, n. 2, p. 1, doi. 10.1002/cnr2.1981

By:

Murakami, Yosuke;
Kawashima, Yosuke;
Chiba, Shinji;
Hara, Shuichiro;
Yamazaki, Yusuke;
Doman, Tsuyoshi;
Saito, Shin;
Odaka, Tetsuo;
Ogasawara, Takahiro;
Shimizu, Hisashi;
Sugisaka, Jun;
Aiba, Tomoiki;
Toi, Yukihiro;
Yamanda, Shinsuke;
Kimura, Yuichiro;
Sugawara, Shunichi

Publication type:

Article